Report Overview

An increasing focus on preventive healthcare and reducing high burden of genetic disorders, rising disposable income, growing government initiatives for prenatal screening and genetic counseling are promoting telemedicine, and cost-effectiveness compared to in-house radiology departments are expected to drive the India Carrier Screening Market during the forecast period between 2024 and 2030.

India Carrier Screening Market – Industry Trends & Forecast Report, 2030

The India Carrier Screening Market size was estimated at USD 652.18 million in 2023. During the forecast period between 2024 and 2030, the India Carrier Screening Market size is projected to grow at a CAGR of 7.89% reaching a value of USD 983.76 million by 2030. Prominent drivers of the market are the increasing investment from both public and private sectors and rising demand for genetic tests. Accessible screening technologies are deemed crucial in this regard. Notably, the market is being shaped by the introduction of new tests that enhance diagnosis and treatment, spurred by an increase in genetic abnormalities and chronic diseases. There is significant growth and innovation in the diagnostic and biotechnology sectors, particularly concerning the adoption of carrier screening technology. This growth is fueled by the escalating incidence of genetic diseases, which presents opportunities for market expansion. Major players on a global scale are launching new tests equipped with advanced technology, expected to have a positive impact on market growth. Also, the carrier screening market is anticipated to expand, especially in developing nations, due to higher prevalence rates of genetic disorders, increasing diagnostic practices, and a growing demand for screening services. Emerging economies are witnessing rapid development in their healthcare industries, supported by government investments and the establishment of biotechnological companies. Additionally, the affordability of carrier screening tests is likely to play a significant role in their adoption.

Carrier Screening – Overview

Carrier screening is a genetic testing method that detects the presence of certain gene mutations linked to genetic disorders. It helps assess the risk of passing on these disorders to offspring if conducted prior to or during pregnancy. Samples such as blood, saliva, or cheek tissue are analyzed for genetic abnormalities. Results indicate either a negative, indicating the absence of the gene, or positive, indicating its presence. Typically, the partner with the higher likelihood of being a carrier undergoes testing first. If they test negative, further testing is unnecessary. However, if they test positive, the other partner is then screened.

India Carrier Screening Market

Growth Drivers

High Burden of Genetic Disorders

Genetic disorders exert a significant burden due to their impact on health and society. Early detection is vital for effective management. Disorders like Tay-Sachs disease, sickle cell anemia, and cystic fibrosis are particularly challenging. Carrier testing helps couples assess the risk of passing on genetic conditions. Pre-symptomatic testing enables proactive management before symptoms appear. Early detection during pregnancy allows for informed decisions and interventions. The rising demand for reliable carrier tests reflects the pressing need to address the burden of genetic disorders. Integrating testing into routine care benefits patients and has commercial implications for the healthcare industry.

Challenges

Cost Factors

The growth of the Carrier Screening Market in India is hindered by the cost factor. High costs associated with carrier screening tests limit accessibility for many individuals and families, particularly in low-income communities. Despite the pressing need for genetic testing and early detection of genetic disorders, the prohibitive expenses pose a significant barrier to market expansion. Addressing the cost factor is essential to ensure equitable access to carrier screening services and to facilitate the diagnosis and management of genetic conditions in India.

Impact of Escalating Geopolitical Tensions on India Carrier Screening Market

Geopolitical tensions can have a multifaceted impact on the India Carrier Screening Market. Heightened uncertainties and disruptions in diplomatic relations may lead to economic instability and volatility in financial markets, impacting investment flows and healthcare spending. Such geopolitical instability can disrupt supply chains for medical equipment and technologies, potentially limiting access to carrier screening tests and hindering market growth. Additionally, political tensions may divert government attention and resources away from healthcare initiatives, slowing down regulatory approvals and policy implementations crucial for market development. Therefore, addressing geopolitical tensions is essential to foster a stable environment conducive to the growth of the Carrier Screening Market in India.

India Carrier Screening Market

Segmental Coverage

India Carrier Screening Market – By Type

By type, the India Carrier Screening Market is divided into Targeted Diseases Carrier screening, Expanded Carrier Screening, Customized Panel Testing, and Predesigned Panel Testing segments. The expanded carrier screening segment holds the highest share in the India Carrier Screening Market and is expected to maintain its dominance by type throughout the forecast period. The Emerging Carrier Screening (ECS) method is gaining prominence for its comprehensive approach, screening for various genetic disorders irrespective of ethnic backgrounds. Market players are actively engaging in strategic endeavors like product development to enhance their market presence and competitiveness. Meanwhile, the predesigned panel testing segment is expected to witness the fastest growth rate during the forecast period. It is primarily due to its broad applicability. It's favored in carrier screening for its efficiency, cost-effectiveness, and thorough coverage of genetic conditions. These panels are meticulously crafted, drawing from robust scientific evidence, and focus on clinically significant genetic mutations linked to inherited disorders.

India Carrier Screening Market – By Medical Conditions

Based on medical conditions, the India Carrier Screening Market is divided into Hematologic Conditions, Pulmonary Conditions, and Neurological Conditions segments. The hematologic conditions segment is expected to hold the highest share in the India Carrier Screening Market by medical conditions during the forecast period. Hematologic disorders, such as sickle cell anemia and thalassemia, are prevalent in India, making carrier screening essential for at-risk populations. Additionally, advancements in carrier screening technologies have improved the accuracy and accessibility of tests for hematologic conditions. The growing awareness among healthcare providers and patients about the importance of early detection and management of these disorders further drives the demand for carrier screening in this segment, contributing to its expected dominance in the market.

India Carrier Screening Market – By Technology

Based on technology, the India Carrier Screening Market is divided into DNA Sequencing, PCR (Polymerase Chain Reaction), and DNA Microarray segments. The DNA sequencing segment holds the highest share in the India Carrier Screening Market by technology. It is primarily due to the rising prevalence of genetic diseases and heightened awareness about genetic testing, coupled with expanding applications of the technology. Ethical considerations surrounding genetic testing are diminishing, contributing to market expansion.

India Carrier Screening Market – By End User

On the basis of end user, the India Carrier Screening Market is divided into Hospitals and Medical Centers, Clinical Laboratories, and Fertility Clinics. The hospitals & medical centers segment holds the highest share in the India Carrier Screening Market and is expected to maintain its dominance by end user during the forecast period. These facilities are often the primary points of contact for individuals seeking healthcare services, including genetic testing. Hospitals and medical centers have the necessary infrastructure and expertise to conduct carrier screening tests effectively. Additionally, they serve a wide range of patients, including those at risk of genetic disorders, contributing to their high market share. With their established reputation and accessibility, hospitals and medical centers are expected to maintain their leadership position in the carrier screening market in India.

India Carrier Screening Market – By Region

Geographically, the India Carrier Screening Market is divided into North India, South India, East India, and West India regions.

Competitive Landscape

Major players operating in India Carrier Screening Market include Quest Diagnostics India Pvt Ltd, LabCorp India, Strand Life Sciences Pvt Ltd, Genetix Biotech Asia Pvt Ltd, Eurofins Genomics India Pvt Ltd, SRL Diagnostics, CORE Diagnostics Pvt Ltd, MedGenome Labs Pvt Ltd, Lifecell International Pvt Ltd, Xcode Life Sciences Pvt Ltd, Invitae Corporation, Illumina Inc., and Thermo Fisher Scientific Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2030
	Base Year – 2023
	Estimated Year – 2024
	Forecast Period – 2024–2030
Facts Covered	USD Million
Market Coverage	India
Product/ Service Segmentation	Type, Medical Conditions, Technology, End User, Region
Key Players	Quest Diagnostics India Pvt Ltd, LabCorp India, Strand Life Sciences Pvt Ltd, Genetix Biotech Asia Pvt Ltd, Eurofins Genomics India Pvt Ltd, SRL Diagnostics, CORE Diagnostics Pvt Ltd, MedGenome Labs Pvt Ltd, Lifecell International Pvt Ltd, Xcode Life Sciences Pvt Ltd, Invitae Corporation, Illumina Inc., Thermo Fisher Scientific Inc.

 

By Type

• Targeted Diseases Carrier screening

• Expanded Carrier Screening

• Customized Panel Testing

• Predesigned Panel Testing

By Medical Conditions

• Hematologic Conditions

• Pulmonary Conditions

• Neurological Conditions

By Technology

• DNA Sequencing

• PCR (Polymerase Chain Reaction)

• DNA Microarray

By End User

• Hospitals & Medical Centers

• Clinical Laboratories

• Fertility Clinics

By Region

• North India

• South India

• East India

• West India

1. Research Framework
   1. Research Objective
   2. Product Overview
   3. Market Segmentation
2. Executive Summary
3. India Carrier Screening Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
         1. Focus on preventive healthcare
         2. High burden of genetic disorders
         3. Rising disposable income
         4. Government initiatives for prenatal screening, genetic counseling
      2. Restraints
         1. Limited awareness especially in rural areas
         2. Cost factor
         3. Lack of genetic counselors
      3. Opportunities
         1. Expansion of test panels
         2. Technological advancements (NGS) for affordable & comprehensive tests
         3. Telemedicine & online platforms for wider access
      4. Challenges
         1. Ethical considerations
         2. Regulation & standardization of test procedures
         3. Infrastructure limitations in rural areas
   3. Technological Advancements/Recent Developments
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
4. India Carrier Screening Market: Marketing Strategies
5. India Carrier Screening Market Overview
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
         1. Targeted Diseases Carrier screening
         2. Expanded Carrier Screening
         3. Customized Panel Testing
         4. Predesigned Panel Testing
      2. By Medical Conditions
         1. Hematologic Conditions
         2. Pulmonary Conditions
         3. Neurological Conditions
         4. Others
      3. By Technology
         1. DNA Sequencing
         2. PCR (Polymerase Chain Reaction)
         3. DNA Microarray
         4. Other
      4. By End User
         1. Hospitals and Medical Centers
         2. Clinical Laboratories
         3. Fertility Clinics
         4. Others
      5. By Region
         1. North India
         2. South India
         3. East India
         4. West India
6. North India Carrier Screening Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Medical Conditions
      3. By Technology
      4. By End User
7. South India Carrier Screening Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Medical Conditions
      3. By Technology
      4. By End User
8. East India Carrier Screening Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Medical Conditions
      3. By Technology
      4. By End User
9. West India Carrier Screening Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Medical Conditions
      3. By Technology
      4. By End User
10. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. India Carrier Screening Company Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Escalating Geopolitical Tensions on India Carrier Screening Market
12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. Quest Diagnostics India Pvt Ltd
    2. LabCorp India
    3. Strand Life Sciences Pvt Ltd
    4. Genetix Biotech Asia Pvt Ltd
    5. Eurofins Genomics India Pvt Ltd
    6. SRL Diagnostics
    7. CORE Diagnostics Pvt Ltd
    8. MedGenome Labs Pvt Ltd
    9. Lifecell International Pvt Ltd
    10. Xcode Life Sciences Pvt Ltd
    11. Invitae Corporation
    12. Illumina Inc.
    13. Thermo Fisher Scientific Inc.
    14. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
    1. Qualitative Research
       1. Primary & Secondary Research
    2. Quantitative Research
    3.  Market Breakdown & Data Triangulation
       1.  Secondary Research
       2.  Primary Research
    4.  Breakdown of Primary Research Respondents, By Region
    5.  Assumptions & Limitations

 

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.

 

List of Figures

 

Figure 1       India Carrier Screening Segmentation

Figure 2       India Carrier Screening Market Value Chain Analysis

Figure 3       Company Market Share Analysis, 2023

Figure 4       India Carrier Screening Market Size, By Value (USD Million), 2019–2030

Figure 5       India Carrier Screening Market Share, By Type, By Value, 2019–2030

Figure 6       India Carrier Screening Market Share, By Medical Conditions, By Value, 2019–2030

Figure 7       India Carrier Screening Market Share, By Technology, By Value, 2019–2030

Figure 8       India Carrier Screening Market Share, By End User, By Value, 2019–2030

Figure 9       North India Carrier Screening Market Size, By Value (USD Million), 2019–2030

Figure 10     North India Carrier Screening Market Share, By Type , By Value, 2019–2030

Figure 11     North India Carrier Screening Market Share, By Medical Conditions, By Value, 2019–2030

Figure 12     North India Carrier Screening Market Share, By Technology, By Value, 2019–2030

Figure 13     North India Carrier Screening Market Share, By End User, By Value, 2019–2030

Figure 14     South India Carrier Screening Market Size, By Value (USD Million), 2019–2030

Figure 15     South India Carrier Screening Market Share, By Type , By Value, 2019–2030

Figure 16     South India Carrier Screening Market Share, By Medical Conditions, By Value, 2019–2030

Figure 17     South India Carrier Screening Market Share, By Technology, By Value, 2019–2030

Figure 18     South India Carrier Screening Market Share, By End User, By Value, 2019–2030

Figure 19     East India Carrier Screening Market Size, By Value (USD Million), 2019–2030

Figure 20     East India Carrier Screening Market Share, By Type , By Value, 2019–2030

Figure 21     East India Carrier Screening Market Share, By Medical Conditions, By Value, 2019–2030

Figure 22     East India Carrier Screening Market Share, By Technology, By Value, 2019–2030

Figure 23     East India Carrier Screening Market Share, By End User, By Value, 2019–2030

Figure 24     West India Carrier Screening Market Size, By Value (USD Million), 2019–2030

Figure 25     West India Carrier Screening Market Share, By Type , By Value, 2019–2030

Figure 26     West India Carrier Screening Market Share, By Medical Conditions, By Value, 2019–2030

Figure 27     West India Carrier Screening Market Share, By Technology, By Value, 2019–2030

Figure 28     West India Carrier Screening Market Share, By End User, By Value, 2019–2030

 

 

List of Tables

 

Table 1        India Carrier Screening Market Size, By Value (USD Million), 2019–2030

Table 2        India Carrier Screening Market Share, By Type, By Value, 2019–2030

Table 3        India Carrier Screening Market Share, By Medical Conditions, By Value, 2019–2030

Table 4        India Carrier Screening Market Share, By Technology, By Value, 2019–2030

Table 5        India Carrier Screening Market Share, By End User, By Value, 2019–2030

Table 6        North India Carrier Screening Market Size, By Value (USD Million), 2019–2030

Table 7        North India Carrier Screening Market Share, By Type , By Value, 2019–2030

Table 8        North India Carrier Screening Market Share, By Medical Conditions, By Value, 2019–2030

Table 9        North India Carrier Screening Market Share, By Technology, By Value, 2019–2030

Table 10      North India Carrier Screening Market Share, By End User, By Value, 2019–2030

Table 11      South India Carrier Screening Market Size, By Value (USD Million), 2019–2030

Table 12      South India Carrier Screening Market Share, By Type , By Value, 2019–2030

Table 13      South India Carrier Screening Market Share, By Medical Conditions, By Value, 2019–2030

Table 14      South India Carrier Screening Market Share, By Technology, By Value, 2019–2030

Table 15      South India Carrier Screening Market Share, By End User, By Value, 2019–2030

Table 16      East India Carrier Screening Market Size, By Value (USD Million), 2019–2030

Table 17      East India Carrier Screening Market Share, By Type , By Value, 2019–2030

Table 18      East India Carrier Screening Market Share, By Medical Conditions, By Value, 2019–2030

Table 19      East India Carrier Screening Market Share, By Technology, By Value, 2019–2030

Table 20      East India Carrier Screening Market Share, By End User, By Value, 2019–2030

Table 21      West India Carrier Screening Market Size, By Value (USD Million), 2019–2030

Table 22      West India Carrier Screening Market Share, By Type , By Value, 2019–2030

Table 23      West India Carrier Screening Market Share, By Medical Conditions, By Value, 2019–2030

Table 24      West India Carrier Screening Market Share, By Technology, By Value, 2019–2030

Table 25      West India Carrier Screening Market Share, By End User, By Value, 2019–2030

Table 26      Quest Diagnostics India Pvt Ltd Company Overview

Table 27      Quest Diagnostics India Pvt Ltd Company Overview

Table 28      LabCorp India Company Overview

Table 29      LabCorp India Company Overview

Table 30      Strand Life Sciences Pvt Ltd Company Overview

Table 31      Strand Life Sciences Pvt Ltd Company Overview

Table 32      Genetix Biotech Asia Pvt Ltd Company Overview

Table 33      Genetix Biotech Asia Pvt Ltd Company Overview

Table 34      Eurofins Genomics India Pvt Ltd Company Overview

Table 35      Eurofins Genomics India Pvt Ltd Company Overview

Table 36      SRL Diagnostics Company Overview

Table 37      SRL Diagnostics Company Overview

Table 38      CORE Diagnostics Pvt Ltd Company Overview

Table 39      CORE Diagnostics Pvt Ltd Company Overview

Table 40      MedGenome Labs Pvt Ltd Company Overview

Table 41      MedGenome Labs Pvt Ltd Company Overview

Table 42      Lifecell International Pvt Ltd Company Overview

Table 43      Lifecell International Pvt Ltd Company Overview

Table 44      Xcode Life Sciences Pvt Ltd Company Overview

Table 45      Xcode Life Sciences Pvt Ltd Company Overview

Table 46      Invitae Corporation Company Overview

Table 47      Invitae Corporation Company Overview

Table 48      Illumina Inc. Company Overview

Table 49      Illumina Inc. Company Overview

Table 50      Thermo Fisher Scientific Inc. Company Overview

Table 51      Thermo Fisher Scientific Inc. Company Overview

Table 52      Other Prominent Players Company Overview

Table 53      Other Prominent Players Company Overview